Table 1 Descriptive characteristics of 314 patients treated with transurethral resection for T1HG Bladder carcinoma between 2011 and 2007
From: Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
Variables | Overall population (n = 314, 100 %) |
|---|---|
Number recurrence | 115 (36.6 %) |
Number progression | 33 (10.5 %) |
Gender | |
Male | 275 (87.6 %) |
Female | 39 (12.4 %) |
Age | |
Mean | 71.3 |
Median (IQR) | 72 (64–79) |
Recurrence (EAU classification) | |
First episode | 218 (69.4 %) |
Recurrent episode | 90 (28.7 %) |
More than 1 episode | 6 (1.9 %) |
Focality | |
1 | 140 (44.6 %) |
2 | 24 (7.6 %) |
3 | 66 (21.0 %) |
No data | 84 (26.8 %) |
Pure transitional | 281 (89.5 %) |
Areas of divergent differentiation | 33 (10.5 %) |
CIS | 54 (17.2 %) |
LVI | 33 (10.5 %) |
SUB-STAGING | |
MM level feasibility | 230 (73.2 %) |
van Rhijn system feasibility | 314 (100 %) |
ROL system feasibility | 314 (100 %) |
Muscolaris Mucosae | |
Above (T1a) | 177 (56.4 %) |
Below (T1b) | 51 (16.2 %) |
van Rhijn | |
T1m | 109 (34.7 %) |
T1e | 205 (65.3 %) |
ROL | |
1 | 152 (48.4 %) |
2 | 162 (51.6 %) |
ROL FOCI | |
2/3 | 31 (9.9 %) |
> 3 | 99 (31.5 %) |